[AMPH] Amphastar Pharmaceuticals, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 20.43 Change: 0.37 (1.84%)
Ext. hours: Change: 0 (0%)

chart AMPH

Refresh chart

Strongest Trends Summary For AMPH

AMPH is in the medium-term up 25% in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company?s products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS0.15 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 16.09% Sales Growth - Q/Q1.81% P/E110.8
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-2.46% ROE-3.49% ROI-3.08%
Current Ratio2.81 Quick Ratio1.63 Long Term Debt/Equity0.27 Debt Ratio0.26
Gross Margin23.49% Operating Margin-10.51% Net Profit Margin-4.4% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.45 M Cash From Investing Activities-5.04 M Cash From Operating Activities1.34 M Gross Profit13.28 M
Net Profit-670 K Operating Profit-7.26 M Total Assets396.5 M Total Current Assets202.6 M
Total Current Liabilities72.09 M Total Debt48.42 M Total Liabilities117.22 M Total Revenue56.89 M
Technical Data
High 52 week25.28 Low 52 week14.63 Last close20.16 Last change1.2%
RSI46.53 Average true range0.55 Beta0.91 Volume248.19 K
Simple moving average 20 days-2.85% Simple moving average 50 days-9.46% Simple moving average 200 days0.59%
Performance Data
Performance Week-3.86% Performance Month-3.72% Performance Quart-8.7% Performance Half8.21%
Performance Year3.07% Performance Year-to-date1.31% Volatility daily1.54% Volatility weekly3.44%
Volatility monthly7.06% Volatility yearly24.45% Relative Volume233.02% Average Volume192.15 K
New High New Low

News

2019-04-15 09:30:00 | Small Cap Pot Stocks Can Bring Investors High Profits-THC Therapeutics, Inc.

2019-04-10 09:30:01 | MNK vs. AMPH: Which Stock Is the Better Value Option?

2019-03-26 17:32:59 | Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote

2019-03-25 09:30:01 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?

2019-03-19 07:40:42 | The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed

2019-03-19 06:00:00 | Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL 100mg/mL Multiple Dose Vial

2019-03-15 07:48:08 | Amphastar Pharmaceuticals Inc AMPH Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-03-13 16:17:11 | This Biotech Sees Markets Worth Billions — But Can It Survive A 'Pause'?

2019-03-13 10:24:20 | Does Market Volatility Impact Amphastar Pharmaceuticals, Inc.’s NASDAQ:AMPH Share Price?

2019-03-13 09:24:10 | Edited Transcript of AMPH earnings conference call or presentation 12-Mar-19 9:00pm GMT

2019-03-13 02:36:44 | Amphastar Pharmaceuticals AMPH Q4 2018 Earnings Conference Call Transcript

2019-03-12 19:10:11 | Amphastar Pharmaceuticals AMPH Beats Q4 Earnings and Revenue Estimates

2019-03-12 18:16:14 | Amphastar: 4Q Earnings Snapshot

2019-03-12 16:05:00 | Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018

2019-03-12 15:00:00 | Amphastar Pharmaceuticals Inc to Host Earnings Call

2019-03-12 07:31:32 | Amphastar Pharmaceutical Q4 Earnings Preview

2019-03-08 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?

2019-03-07 16:01:00 | Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019

2019-02-26 08:15:00 | Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental — Emerging Consolidated Expectations, Analyst Ratings

2019-02-13 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?

2019-01-29 13:38:39 | Who Has Been Selling Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH Shares?

2019-01-28 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?

2019-01-11 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?

2019-01-03 06:00:00 | Amphastar Pharmaceuticals, Inc. Announces Launch of Primatene® MIST to Nationwide Retail Pharmacies

2018-12-25 09:30:02 | BHC vs. AMPH: Which Stock Is the Better Value Option?

2018-12-23 21:20:33 | Is Amphastar Pharmaceuticals Inc AMPH A Good Stock To Buy?

2018-12-21 11:04:50 | How Much Did Amphastar Pharmaceuticals, Inc.’s NASDAQ:AMPH CEO Pocket Last Year?

2018-12-03 08:52:01 | Amphastar Pharmaceuticals AMPH Catches Eye: Stock Jumps 6.7%

2018-11-27 08:45:00 | New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-11-22 09:30:02 | BHC or AMPH: Which Is the Better Value Stock Right Now?

2018-11-21 10:42:17 | What You Must Know About Amphastar Pharmaceuticals Inc’s NASDAQ:AMPH Financial Strength

2018-11-20 16:05:00 | Amphastar Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference 2018

2018-11-09 06:00:00 | Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018

2018-11-08 21:37:03 | Edited Transcript of AMPH earnings conference call or presentation 8-Nov-18 10:00pm GMT

2018-11-08 21:32:22 | Amphastar Pharmaceuticals Inc AMPH Q3 2018 Earnings Conference Call Transcript

2018-11-08 20:40:01 | Amphastar Pharmaceuticals AMPH Matches Q3 Earnings Estimates

2018-11-08 19:33:25 | Amphastar: 3Q Earnings Snapshot

2018-11-08 16:10:00 | Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018

2018-11-07 21:55:38 | Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST

2018-11-06 16:05:00 | Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018

2018-11-06 09:30:02 | MNK or AMPH: Which Is the Better Value Stock Right Now?

2018-11-02 16:05:00 | Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018

2018-10-16 09:15:00 | Consolidated Research: 2018 Summary Expectations for Freightcar America, Star Bulk Carriers, Avis Budget Group, Adamas Pharmaceuticals, Model N, and Amphastar Pharmaceuticals — Fundamental Analysis, Key Performance Indications

2018-10-12 10:18:11 | Who Are The Major Shareholders In Amphastar Pharmaceuticals Inc NASDAQ:AMPH?

2018-10-02 09:30:01 | MNK or AMPH: Which Is the Better Value Stock Right Now?

2018-09-13 09:30:01 | AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?

2018-08-29 16:05:00 | Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018

2018-08-27 09:30:01 | AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?

2018-08-22 15:40:10 | Edited Transcript of AMPH earnings conference call or presentation 8-Aug-18 9:00pm GMT

2018-08-20 08:00:00 | Investor Expectations to Drive Momentum within Rapid7, 1-800 FLOWERS.COM, SMART Global, Prothena Corporation plc, Amphastar Pharmaceuticals, and Silvercorp Metals — Discovering Underlying Factors of Influence